Page 15 - Kumar Paul News Today : Breaking News, Live Updates & Top Stories | Vimarsana

4 Min Read NEW DELHI (Reuters) -India’s most populous state will spend up to $1.36 billion to buy COVID-19 shots and held early talks this week with companies such as Pfizer and the local partner of the maker of Russia’s Sputnik V, a state official said on Thursday. A man speaks on the phone as a doctor tries to revive his wife inside an emergency ward of a government-run hospital, amidst the coronavirus disease (COVID-19) pandemic, in Bijnor district, Uttar Pradesh, India, May 11, 2021. REUTERS/Danish Siddiqui The move by Uttar Pradesh, home to more people than Brazil, comes as many Indi...

Exclusive-India's most populous state to spend up to $1.36 billion on COVID shots amid shortage By Krishna N. Das Reuters NEW DELHI (Reuters) -India's most populous state will spend up to $1.36 billion to buy COVID-19 shots and held early talks this week with companies such as Pfizer and the local partner of the maker of Russia's Sputnik V, a state official said on Thursday. The move by Uttar Pradesh, home to more people than Brazil, comes as many Indian states curtail vaccinations due to severe shortages amid a record surge in coronavirus infections, with India recording more than 4,000 deat...

Integrated participatory efforts to combat drug abuse stressed 385 RAJSHAHI, May 10, 2021 (BSS)- Integrated participatory efforts of all government and non-government entities concerned have become crucial to combat the abuses of drugs along with its illicit trading and trafficking. There is no alternative to make all the existing movements and efforts of preventing drug abuse effective and fruitful to protect the young generation from further degradation. Administrative officials and development activists came up with the observations while addressing a virtual roundtable meeting with media ...

Reuters Reuters 28 April, 2021, 2:11 pm FILE PHOTO: An ampule of Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (COVID-19) continues. Ulrich Perrey/Pool via REUTERS (Reuters) – U.S. drugmaker Merck & Co joined Gilead Sciences on Tuesday in lending support to India as the world’s second-most populous country scrambles to address drug shortages and bring a raging new wave of COVID-19 cases under control. Gilead said it would give India at least 450,000 vials of its antiviral...

  Gilead Sciences Inc said on Monday it will give India at least 450,000 vials of its antiviral drug remdesivir and help boost production, as the world's second-most populous country reels from surging coronavirus cases. Remdesivir is approved in India for restricted emergency use to treat severe COVID-19 cases, but hospitals are facing supply shortages due to indiscriminate use and the drug is being sold at over 10 times its listed price in the black market. The shortage has raised concerns about hoarding as people queue up outside clinics and hospitals to buy the drug and millions take ...